drugset / Trial / NCT03893669
Safety, Tolerability and Immunogenicity of an Trivalent Inactivated Cell-Culture Influenza Vaccine in Healthy Adults
RandomizedParallel-groupQuadruple-blindPrevention
Summary
A randomized, double-blinded, controlled, Phase I clinical trial to assess the safety, tolerability and immunogenicity of 'NBP607(trivalent inactivated cell-culture influenza vaccine)' compared to egg-based influenza vaccine in healthy adult volunteers
Timeline
- Start
- 2012-09
- Primary completion
- 2012-10
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Agrippal | Vaccine | 0.5 ml | Intramuscular |
| Subject | NBP607 | Vaccine | 0.5 ml | Intramuscular |
Indications
No indication recorded.